Morgan Stanley’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Morgan Stanley’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-177,661	Closed	-$3.32M	–	8273
2022 Q1	$3.32M	Sell	177,661 -82,281	-32%	-$1.48M	﹤0.01%	4105
2021 Q4	$5.56M	Sell	259,942 -93,770	-27%	-$1.85M	﹤0.01%	3609
2021 Q3	$6.54M	Buy	353,712 +89,978	+34%	+$1.81M	﹤0.01%	3401
2021 Q2	$5.65M	Buy	263,734 +11,216	+4%	+$228K	﹤0.01%	3654
2021 Q1	$4.87M	Buy	+252,518	New	+$4.45M	﹤0.01%	3441

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Morgan Stanley's OCDX Position: Q2 2022 in Review

Morgan Stanley sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 177,661 shares — an estimated $3.32M sold.

Morgan Stanley first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $6.54M in Q3 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Morgan Stanley reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Morgan Stanley sold 177,661 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $3.32M.
Morgan Stanley first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Morgan Stanley's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $6.54M in Q3 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Morgan Stanley's 13F filing for Q2 2022, filed 15 Aug 2022.